Iodomethane

Iodomethane

SCHEMBL861811

CC(=O)CCCc1ccc2c(ccn2[Si](C(C)C)(C(C)C)C(C)C)c1.CI.[MgH2]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OXER1 Q8TDS5 2/20 0.39
S1PR1 P21453 1/20 0.38
CYP1A2 P05177 2/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAPT P10636 1/20 0.35
MAOA P21397 1/20 0.35
SLC6A2 P23975 1/20 0.35
RAB9A P51151 1/20 0.35
SLC6A3 Q01959 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ITGB3 P05106 2/20 0.33
ITGAV P06756 2/20 0.33
ITGB5 P18084 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL861052 0.96 OXER1 (0.41) OXER1S1PR1CYP1A2KDM4ENPC1
SCHEMBL861812 0.93 OXER1 (0.38) OXER1S1PR1CYP1A2KDM4ENPC1
SCHEMBL5154395 0.79 KDM4E (0.35) OXER1S1PR1KDM4EMAPTHDAC1
SCHEMBL3035285 0.74 AKR1C3 (0.39) CYP1A2LMNAMAPTSMN1; SMN2HDAC8
SCHEMBL30711626 0.73 HTR2C (0.35)
SCHEMBL1860633 0.72 CACNA1H (0.36) OXER1KDM4EMAPTHSD17B10ACACB
SCHEMBL13837234 0.71 PARP1 (0.32)
SCHEMBL17275595 0.69 RAPGEF4 (0.45) KDM4ESMN1; SMN2HSD17B10
SCHEMBL3327014 0.68 MAPT (0.33) MAPT
SCHEMBL2502244 0.68 KDM4E (0.36) CYP1A2KDM4EMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425010-B8 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICALS INC (US) 2012-03-28 EP disclosed
EP-1425010-A4 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-07-29 EP disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed